Navigation Links
60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG
Date:2/16/2008

BIRMINGHAM, Ala., Feb. 15 /PRNewswire/ -- Cory Watson Crowder & DeGaris, P.C. (http://www.cwcd.com), has filed lawsuits against Bayer AG on behalf of plaintiffs throughout the United States, who allegedly suffered permanent kidney damage after being given Trasylol(R) -- a Bayer-manufactured drug used to prevent excessive bleeding during coronary artery bypass graft surgery (also called CABG or more commonly bypass). According to CBS News, 60 Minutes will report Sunday night that 22,000 additional lives could have been saved had the FDA taken action to remove Trasylol from the market in 2006. Dr. Dennis Mangano, a leading researcher in the field, whose January 2006 New England Journal of Medicine article set out the dangers of Trasylol (also known as aprotinin), reports that Bayer AG had done internal studies that were not presented to the FDA at a September 2006 advisory panel meeting that would have confirmed the dangers of this drug. FDA eventually requested marketing suspension of Trasylol, which finally occurred in November of 2007. The market suspension is now worldwide.

"This drug, which most patients never knew they received during their surgery, has caused significant injuries and loss of life due to severe and possibly life-threatening kidney problems," said Brian D. Turner, Jr., shareholder at Cory Watson Crowder & DeGaris, the law firm that filed the first two cases in the nation against Bayer regarding Trasylol. Turner said, "That this drug company had information that could have saved lives and did not make that information known is reprehensible and Bayer needs to be held accountable."

According to German scientist, Dr. Juergen Fischer, who was interviewed for the 60 Minutes segment, Bayer AG has known since the 1980s that Trasylol caused severe kidney damage, but undertook no study during the drug's development to look at these side effects. Earlier this month, an article in The Lancet brought the debate over Trasylol back into the spotlight when a retrospective study showed risks related to Trasylol to be more prevalent with certain surgical procedures. Dr. Mangano's observational study of over 5,000 patients in 17 countries, published in the New England Journal of Medicine in January 2006, showed that Trasylol doubled the risk of kidney failure in patients. A Canadian study on the effects of Trasylol, known as BART (Blood conservation using Antifibrinolytics in a Randomized Trial), was halted in October 2006 when the drug appeared to have an increased risk of death compared to other drugs in the study.

About Cory Watson Crowder & DeGaris P.C.

Cory Watson Crowder & DeGaris was founded in 1995 and has become known as one of the region's leading law firms devoted to representing individuals and businesses injured by the wrongful conduct of others. Some of the senior shareholders in the firm have 25 years of legal experience and have represented clients all across the United States and beyond including Africa, Greece, Latin America, and Canada. The firm's experienced attorneys and staff handle a variety of cases. The largest area of the firm's practice is products liability, including litigation of defective consumer and household products, motor vehicles, medical devices, and pharmaceuticals. Other practice areas include business litigation, personal injury, nursing home negligence, insurance law, civil rights, class action lawsuits, employment law, workers' compensation, and construction accidents. Visit http://www.cwcd.com for more information.


'/>"/>
SOURCE Cory Watson Crowder & DeGaris, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. iPlan(R) Automatic Segmentation Saves 25 Minutes of Treatment Planning Time for Each Prostate Cancer Patient at the University of Nebraska Medical Center
2. It Only Takes Minutes a Day to Strike It Healthy for the Holidays, Expert Says
3. New Automated System IDs Victims of Mass Disasters in Minutes
4. New Automated System Can ID Disaster Victims in Minutes
5. Join the Vitamin D Revolution: How to Get 30 Minutes of Daily Sunshine for Optimal Health
6. 11 Minutes or 90 Seconds?
7. Virginia Tech Report Has National Importance
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
10. Haemacure Reports Third Quarter 2007 Results
11. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: